Parent Interventions: A Healthy Breakfast for Your Child  |  Leadership Instincts: IITH-NIMS Joint Research Centre to be Set up in Japan  |  Teacher Insights: Disruptive Students Affect Teachers’ Well Being  |  Teacher Insights: Old and Young Perfect Friends  |  Science Innovations: Mango Round the Year  |  Science Innovations: Hand Held Device to Detect Dengue  |  Parent Interventions: Political Ad Campaigns Add to Anxiety  |  Policy Indications: Streamlining Compliance in Higher Education  |  Technology Inceptions: Canon Super Telephoto RF Prime L Lenses  |  Technology Inceptions: Boya BY-WM4 Pro Wireless Mic  |  Technology Inceptions: Microsoft Edge Kids Mode  |  Life Inspirations: In Search of Heaven  |  National Edu News: 71st RRT Conference International on Appropriate Pedagogy of the Digital Natives  |  Guest Column: Collaboration + Research = Global Solutions   |  Teacher Insights: How Digital Technology Helps in Growth and Access to Quality Education  |  
March 23, 2020 Monday 10:09:28 AM IST

Proposals invited on COVID-19 & related respiratory viral infections

Science Innovations

COVID-19 virus has spread rapidly throughout the world. Given the lack of an efficacious vaccine and lack of availability of suitable chemotherapeutic interventions, the global population has been hit hard to the current coronavirus outbreak.

Science & Engineering Research Board (SERB), an autonomous institution of the Department of Science & Technology, invites proposals as part of special call under IRHPA (Intensification of Research in High Priority Area) scheme specifically designed for COVID-19 and related respiratory viral infections to ramp up national R&D efforts for new antivirals, vaccines, and affordable diagnostics.

Academic and research institutions have been encouraged to submit competitive proposals having a strong interdisciplinary component between chemists, biologists, virologists, immunologists, and clinicians, in the related areas and to focus on the development of affordable diagnostics, vaccines, antivirals, disease models and other R&D to study these infections.

One of the participating institutions should have access to BSL-3 (Bio-safety level 3) and above facilities, along with the expertise of handling respiratory viruses as per WHO/Govt. of India protocols.


DST-SERB encourages technical partnerships and collaborative know-how from biotech and pharmaceutical companies. SERB is committed for strategic investments to accelerate antiviral research.

The Proposals may be submitted as per SERB-IRHPA format by 5 pm on Monday the 30th March 2020, through the SERB online portal.

The proposals may focus on some of the key themes such as-

New or repurposed antivirals against valid viral targets; viricidal coatings; etc.


Affordable diagnostics for symptomatic and asymptomatic respiratory viral infections

Investigational vaccines against respiratory viruses

Response of virus to temperature, humidity & UV radiation

Development of disease models for respiratory viral infections


Studies on immune response and immunity during respiratory viral infections

Epidemiology of COVID-19 and other respiratory viral infections

(For further details, please visit: http://www.serb.gov.in/home.php)


Comments